2
0Canon is undergoing a major transformation under its “Excellent Global Corporation Plan Phase VI” (2021–2025), shifting from its legacy camera and office equipment businesses toward four growth pillars: Commercial Printing, Network Cameras, Medical Systems, and Industrial Equipment. The company targets over ¥4.5 trillion in sales and record profitability by 2025, supported by strong post-pandemic recovery, high-value products, and restructuring of its global production network, including reshoring advanced manufacturing to Japan.
Canon’s Printing and Imaging groups are expanding in commercial presses, cloud services, mirrorless cameras, and fast-growing network camera markets. The Medical Group aims for profitability improvements and leadership in CT and next-generation Photon Counting CT. The Industrial Group is scaling semiconductor lithography capacity and commercializing nanoimprint lithography for advanced chips.
Canon continues heavy R&D investment (8%+ of revenue), leading in U.S. patents and developing technologies such as NIL, PCCT, advanced materials, AI-based design, and simulation platforms. Guided by its Kyosei philosophy, Canon is advancing ESG goals, including SBTi-certified net-zero CO2 by 2050. Strengthened governance, global risk management, and workforce development support its long-term transformation into a diversified industrial technology leader.
